Anticoagulant
Pregnancy: Contraindicated — no safety data; crosses placenta; use LMWH
Apixaban
Brand names: Eliquis
Adult dose
Dose: AF stroke prevention: 5mg BD. VTE treatment: 10mg BD × 7 days, then 5mg BD
Route: Oral
Frequency: Twice daily
Max: 10mg BD (treatment phase)
AF: reduce to 2.5mg BD if ≥2 of: age ≥80, weight ≤60kg, creatinine ≥133 micromol/L. VTE extended: 2.5mg BD after ≥6 months treatment. Pulmonary embolism: 10mg BD × 7 days, then 5mg BD × 6 months minimum.
Dose adjustments
Renal
CrCl 15–29 ml/min: consider dose reduction. CrCl <15 ml/min or dialysis: avoid (limited data).
Hepatic
Avoid in severe hepatic impairment (Child-Pugh C) or coagulopathy.
Clinical pearls
- ARISTOTLE trial: apixaban vs warfarin in AF — 21% reduction in stroke/SE, 31% reduction in major bleeding, 11% reduction in all-cause mortality.
- Reversal agent: andexanet alfa (Ondexxya) for life-threatening bleeding. Alternatively: 4-factor PCC 25–50 units/kg (unlicensed).
- Half-life ~12h — no monitoring required in standard use. Ensure twice-daily compliance.
- Renal dose reduction criteria (2.5mg BD in AF): two or more of — age ≥80, weight ≤60kg, creatinine ≥133 micromol/L.
Contraindications
- Active major haemorrhage
- Mechanical prosthetic heart valves (DOACs contraindicated)
- Antiphospholipid syndrome with triple positivity
- Significant hepatic impairment with coagulopathy
- CrCl <15 ml/min
Side effects
- Bleeding (major: 2.1%/year in ARISTOTLE — less than warfarin)
- Anaemia
- Nausea
- Bruising
Interactions
- Strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir): increase apixaban — avoid combination
- Strong CYP3A4 and P-gp inducers (rifampicin, carbamazepine, phenytoin): reduce apixaban — avoid
- Aspirin / NSAIDs: additive bleeding risk
Monitoring
- No routine coagulation monitoring required. Annual eGFR and LFTs. Hb if bleeding suspected.
Reference: ARISTOTLE Trial NEJM 2011; NICE TA275 (AF); NICE TA341 (VTE); NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Same class
Drugs
Same class
Pathways
Same specialty
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines